Page 28 - B Program News Today

This weekly series provides brief summaries to help you stay in the know on how 340B cases are developing across the country. Each week we comb through the dockets of more than 50 340B...

Central Vermont Medical Center (CVMC) erves a population of 66,000 and employs nearly 1,400 people in one of the most rural regions of the country. The not-for-profit community health care provider treats more than 25,000 patients through its Emergency Department, provides care to over 164,000 Vermonters in its 27 outpatient facilities, and performs over 3,000 outpatient surgeries annually.

FDA activities, such as routine inspections, may be delayed, but the agency will continue to review drug and medical device approval applications while user fee carryover funds remain.

Tyler Clementi Higher Education Anti-Harassment Act of 2023 comes as harassment and bullying, especially of LGBTQ+ community, on the rise

In July 2023, the Centers for Medicare and Medicaid Services (“CMS”) proposed a final rule to address illegal traditional Medicare rates paid in the 340B Drug Pricing Program from...

The 340B Drug Pricing Program (the "Program") allows certain healthcare providers ("covered entities") to purchase pharmaceuticals from drug manufacturers at discounted rates.

Southwestern Vermont Health Care (SVHC) is an integrated non-profit health system serving over 75,000 patients annually from Southwestern Vermont, parts of eastern New York, and northern Massachusetts.

The Inflation Reduction Act’s Medicare Drug Price Negotiation Program will kick off next week. The statute sets a deadline of September 1, 2023 for the Secretary of Health and Human...

In this episode, Darlene Davis, Leah Richardson, and Andrew Ruskin unravel CMS’s proposed rule for the remedy for Medicare payments for drugs purchased under the 340B Program and...

The American Hospital Association opposes a proposed limit to the 340B Drug Pricing Program, stating it would reduce access to vital medications.